Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phathom Pharmaceuticals (PHAT) Current Leases: 2022-2025

Historic Current Leases for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Sep 2025 value amounting to $591,000.

  • Phathom Pharmaceuticals' Current Leases fell 13.09% to $591,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $591,000, marking a year-over-year decrease of 13.09%. This contributed to the annual value of $501,000 for FY2024, which is 30.99% down from last year.
  • Latest data reveals that Phathom Pharmaceuticals reported Current Leases of $591,000 as of Q3 2025, which was up 148.32% from $238,000 recorded in Q2 2025.
  • In the past 5 years, Phathom Pharmaceuticals' Current Leases registered a high of $730,000 during Q1 2024, and its lowest value of $238,000 during Q2 2025.
  • Its 3-year average for Current Leases is $604,727, with a median of $712,000 in 2023.
  • In the last 5 years, Phathom Pharmaceuticals' Current Leases spiked by 45.31% in 2023 and then plummeted by 66.94% in 2025.
  • Over the past 4 years, Phathom Pharmaceuticals' Current Leases (Quarterly) stood at $708,000 in 2022, then grew by 2.54% to $726,000 in 2023, then tumbled by 30.99% to $501,000 in 2024, then decreased by 13.09% to $591,000 in 2025.
  • Its Current Leases was $591,000 in Q3 2025, compared to $238,000 in Q2 2025 and $316,000 in Q1 2025.